Region: Germany

The Unified Patent Court has handed patentees a win and a loss in its first on-the-merits rulings

04 July 2024

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Europe is one of the most important markets for the life sciences and pharma industry, and Germany is one of its key jurisdictions. Patenting life science inventions in Germany can be challenging as some biological subject matter is excluded from patent protection, so careful patent drafting is crucial in order to obtain allowable claims.

24 June 2024

New IP Hall of Fame member speaks to IAM about the key moments of the Unified Patent Court’s first 12 months

20 June 2024

Saturday Opinion: The Bundeskartellamt’s decision to give the green light to an automotive licensing negotiation group could stir up further disputes among licensors and licensees

15 June 2024

Patentee’s NPE status worked against it, Unified Patent Court judges stated

04 June 2024

But the covid-19 jab maker must overcome several more hurdles to get its hands on a slice of Pfizer/BioNTech’s vaccine revenues

20 May 2024

After almost one year, the new court has offered both encouraging and discouraging signs for IP owners seeking interim sales and manufacturing bans

14 May 2024

Following buyout by Bruker, NanoString has struck another blow in worldwide patent dispute against its spatial biology rival

13 May 2024

Docket Navigator data shows soaring popularity of Munich and Mannheim Local Divisions require the appointment of new judges

06 May 2024

Chinese implementer must now fight to remain in Europe’s largest market

03 May 2024